DrugPatentWatch Database Preview
MINOCIN Drug Profile
» See Plans and Pricing
When do Minocin patents expire, and what generic alternatives are available?
Minocin is a drug marketed by Bausch, Triax Pharms, Lederle, and Rempex Pharms. and is included in five NDAs. There are two patents protecting this drug.
This drug has thirty patent family members in twenty-two countries.
The generic ingredient in MINOCIN is minocycline hydrochloride. There are fifteen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the minocycline hydrochloride profile page.
US ANDA Litigation and Generic Entry Outlook for Minocin
A generic version of MINOCIN was approved as minocycline hydrochloride by WATSON LABS on December 30th, 1991.
Summary for MINOCIN
| International Patents: | 30 |
| US Patents: | 2 |
| Applicants: | 4 |
| NDAs: | 5 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 36 |
| Clinical Trials: | 35 |
| Patent Applications: | 4,087 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for MINOCIN |
| What excipients (inactive ingredients) are in MINOCIN? | MINOCIN excipients list |
| DailyMed Link: | MINOCIN at DailyMed |
Recent Clinical Trials for MINOCIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Sun Yat-sen University | Phase 2 |
| St. Louis Children's Hospital | Phase 2 |
| University of Washington | Phase 2 |
Pharmacology for MINOCIN
| Drug Class | Tetracycline-class Drug |
US Patents and Regulatory Information for MINOCIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch | MINOCIN | minocycline hydrochloride | CAPSULE;ORAL | 050649-001 | May 31, 1990 | AB | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
| Rempex Pharms | MINOCIN | minocycline hydrochloride | INJECTABLE;INJECTION | 050444-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Triax Pharms | MINOCIN | minocycline hydrochloride | CAPSULE;ORAL | 050315-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Rempex Pharms | MINOCIN | minocycline hydrochloride | INJECTABLE;INJECTION | 050444-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Bausch | MINOCIN | minocycline hydrochloride | CAPSULE;ORAL | 050649-003 | Feb 12, 2001 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for MINOCIN
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2011143503 | Start Trial |
| Japan | 2013529201 | Start Trial |
| European Patent Office | 2568987 | Start Trial |
| Poland | 2568987 | Start Trial |
| Portugal | 2568987 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
